FDA Approved Semaglutide: Leading Rapid Weight Loss Drug
Understanding Semaglutide’s Mechanism: A Paradigm Shift in Weight Loss Pharmacotherapy Semaglutide, an FDA approved glucagon-like peptide-1 (GLP-1) receptor agonist, has emerged as a transformative agent in the landscape of obesity management. Distinguished by its potent incretin-mimetic properties, semaglutide modulates appetite regulation centers in the hypothalamus, enhancing satiety and reducing caloric intake, thereby facilitating substantial weight … Read more